These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
179 related items for PubMed ID: 21262116
1. Exertional rhabdomyolysis after influenza A (H3N2) infection in a basketball player boy. Sevketoglu E, Kural B, Beskardes AE, Hatipoglu S. Ann Trop Paediatr; 2011; 31(1):93-6. PubMed ID: 21262116 [Abstract] [Full Text] [Related]
3. Efficacy of oseltamivir treatment started within 5 days of symptom onset to reduce influenza illness duration and virus shedding in an urban setting in Bangladesh: a randomised placebo-controlled trial. Fry AM, Goswami D, Nahar K, Sharmin AT, Rahman M, Gubareva L, Azim T, Bresee J, Luby SP, Brooks WA. Lancet Infect Dis; 2014 Feb; 14(2):109-18. PubMed ID: 24268590 [Abstract] [Full Text] [Related]
4. Different drug-resistant influenza A(H3N2) variants in two immunocompromised patients treated with oseltamivir during the 2011-2012 influenza season in Italy. Piralla A, Gozalo-Margüello M, Fiorina L, Rovida F, Muzzi A, Colombo AA, Alessandrino PE, Baldanti F. J Clin Virol; 2013 Sep; 58(1):132-7. PubMed ID: 23810646 [Abstract] [Full Text] [Related]
11. Lower clinical effectiveness of oseltamivir against influenza B contrasted with influenza A infection in children. Sugaya N, Mitamura K, Yamazaki M, Tamura D, Ichikawa M, Kimura K, Kawakami C, Kiso M, Ito M, Hatakeyama S, Kawaoka Y. Clin Infect Dis; 2007 Jan 15; 44(2):197-202. PubMed ID: 17173216 [Abstract] [Full Text] [Related]
12. Neuropsychiatric events in an adult patient with influenza a (H3N2) treated with oseltamivir (Tamiflu): a case report. Chen R, Fang Z, Huang Y. BMC Infect Dis; 2019 Mar 04; 19(1):224. PubMed ID: 30832611 [Abstract] [Full Text] [Related]
14. The virologist and the flu. Wicker S, Rabenau HF. J Clin Virol; 2015 Aug 04; 69():200-2. PubMed ID: 26209407 [Abstract] [Full Text] [Related]
15. A novel neuraminidase deletion mutation conferring resistance to oseltamivir in clinical influenza A/H3N2 virus. Abed Y, Baz M, Boivin G. J Infect Dis; 2009 Jan 15; 199(2):180-3. PubMed ID: 19046066 [Abstract] [Full Text] [Related]
17. Rhabdomyolysis induced by influenza A infection: case report and review of literature. Sato E, Nakamura T, Koide H. Ther Apher Dial; 2011 Apr 15; 15(2):208-9. PubMed ID: 21426516 [No Abstract] [Full Text] [Related]
18. Longer virus shedding in influenza B than in influenza A among outpatients treated with oseltamivir. Kawai N, Ikematsu H, Iwaki N, Kawashima T, Maeda T, Mitsuoka S, Kondou K, Satoh I, Miyachi K, Yamaga S, Shigematsu T, Hirotsu N, Kashiwagi S. J Infect; 2007 Sep 15; 55(3):267-72. PubMed ID: 17604839 [Abstract] [Full Text] [Related]
19. Global transmission of oseltamivir-resistant influenza. Moscona A. N Engl J Med; 2009 Mar 05; 360(10):953-6. PubMed ID: 19258250 [No Abstract] [Full Text] [Related]
20. [Successful Treatment of Seasonal Influenza A (H3N2) infection-related Hemophagocytic Lymphocytosis in an Elderly Man]. Suzuki S, Tanaka A, Fukuda Y, Miyata Y, Murata Y, Kishino-Oki Y, Homma T, Ohnishi T, Sagara H. Kansenshogaku Zasshi; 2016 Jan 05; 90(1):77-82. PubMed ID: 27032178 [Abstract] [Full Text] [Related] Page: [Next] [New Search]